Concepedia

Author

Andrew Lewin

National Research Institute

Also Known As

A J Lewin, A. J. Lewin, ANDREW J. LEWIN, ANDREW LEWIN, Andrew J Lewin, Andrew J. Lewin, Andrew Lewin, P Harvey

75

Publications

5.5K

Citations

24

H-Index

43

Concepts

All Affiliations

National Research InstituteBoehringer Ingelheim (Germany)Diabetes & Glandular Disease ClinicNovo Nordisk (Denmark)Pfizer (United States)
AL

About

Andrew Lewin is an author at National Research Institute specializing in medicine, cardiovascular disease, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

17

942

2

Diabetes

6

6

306

3

Public Health

3

3

271

4

Emergency Medicine

1

1

24

5

Epidemiology

1

1

138

Andrew Lewin

×

41

Publications

5.3K

Citations

24

H-Index

YearCitations

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode,

JAMA

2015

1.1K

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, John Gerich, John B. Buse,

Diabetes Care

2009

834

Initiating Insulin Therapy in Type 2 Diabetes

Philip Raskin, Elsie Allen, Priscilla Hollander,

Diabetes Care

2005

557

Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes

Murray Epstein, Gordon H. Williams, Myron H. Weinberger,

Clinical Journal of the American Society of Nephrology

2006

453

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel,

Diabetes Care

2015

284

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

Christof Kazda, Ying Ding, Ronan P. Kelly,

Diabetes Care

2015

210

Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes

Andrew Lewin, Ralph A. DeFronzo, Sanjay Patel,

Diabetes Care

2015

182

Plasma Renin Activity and Blood Pressure in Terminal Renal Failure

P Weidmann, Morton H. Maxwell, Andrei N. Lupu,

New England Journal of Medicine

1971

175

Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals

Theodore Feldman, Michael J. Koren, William Insull,

The American Journal of Cardiology

2004

138

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

Bernard Zinman, Greg Fulcher, Paturi Vishnupriya Rao,

The Lancet

2011

131

Page 1